SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-20-052889
Filing Date
2020-04-29
Accepted
2020-04-29 09:00:23
Documents
6
Period of Report
2020-06-16
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2016453-1_def14a.htm DEF 14A 261606
2 GRAPHIC image_007.jpg GRAPHIC 7769
3 GRAPHIC tm2016453d1_def14a-img01.jpg GRAPHIC 245268
4 GRAPHIC tm2016453d1_def14a-img02.jpg GRAPHIC 207201
5 GRAPHIC sg_lucy-lu.jpg GRAPHIC 15382
6 GRAPHIC sg_joseph-vazzano.jpg GRAPHIC 16837
  Complete submission text file 0001104659-20-052889.txt   941646
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38114 | Film No.: 20827634
SIC: 2834 Pharmaceutical Preparations